Your search for mepolizumab returned 61 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for mepolizumab returned 61 results

Sort Results:

Relevant Recent

Asthma in children has become more prevalent over the last several decades. Treatment options for addressing treatment-resistant, allergic-type severe asthma have advanced in recent years, as research has begun to uncover the pathological processes that underlie asthma phenotypes. In this article, Meyer Kattan, MD, professor of pediatrics at Columbia University and director of the Pediatric Pulmonary Division at New York-Presbyterian/Morgan Stanley Children’s Hospital, discusses state-of-the-art treatments for severe allergic asthma in children and future directions for research.

Mepolizumab 100mg/vial; lyophilized pwd for SC inj after reconstitution; or 100mg/mL, 40mg/0.4mL; soln for SC inj; preservative-free.

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of February. The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on Key: D=Dosing,…